Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for BioCorRx (BICX) over the last 12 years, with Q3 2025 value amounting to -$0.11.

  • BioCorRx's EPS (Weighted Average and Diluted) rose 2142.86% to -$0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.45, marking a year-over-year decrease of 8000.0%. This contributed to the annual value of -$0.0 for FY2010, which is 9772.13% up from last year.
  • According to the latest figures from Q3 2025, BioCorRx's EPS (Weighted Average and Diluted) is -$0.11, which was up 2142.86% from -$0.07 recorded in Q2 2025.
  • In the past 5 years, BioCorRx's EPS (Weighted Average and Diluted) registered a high of -$0.07 during Q2 2025, and its lowest value of -$0.14 during Q3 2024.